Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: Results of a phase I/II trial and ex vivo enhancement by checkpoint blockade.
Oncol. Res. Treat.40, 135-135 (2017)
Open Access Green as soon as Postprint is submitted to ZB.